Cerevel Therapeutics

Advantage BMS as AbbVie drug fails schizophrenia trials
Pharmaphorum
Mon, 11/11/24 - 11:24 am
AbbVie
emraclidine
schizophrenia
Cerevel Therapeutics
clinical trials
Bristol Myers Squibb
Kailera launches with $400M series A and clutch of Chinese obesity drugs
Fierce Biotech
Tue, 10/1/24 - 09:57 am
Kailera Therapuetics
China
funding
obesity
Cerevel Therapeutics
5 Neuro Data Readouts to Watch in the Second Half of 2024
BioSpace
Mon, 07/15/24 - 11:43 am
neurology
clinical trials
Athira Pharma
fosgonimeton
Alzheimer's disease
AbbVie
Cerevel Therapeutics
emraclidine
schizophrenia
Neumora Therapeutics
major depressive disorder
navacaprant
Amylx
AMX003
Wolfram syndrome
Vigil Neuroscience
iluzanebart
Do Karuna, Cerevel Deals Signal Renewed Neuropsychiatric Interest From Big Pharma?
BioSpace
Mon, 06/3/24 - 12:09 pm
Karuna
Cerevel Therapeutics
neuropsychiatric
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
BioPharma Dive
Thu, 04/18/24 - 11:09 am
Cerevel Therapeutics
Parkinson's Disease
tavapadon
Psychosis: The Other Big Alzheimer’s Therapeutic Target
BioSpace
Tue, 04/2/24 - 11:46 am
Alzheimer's disease
Alzheimer's disease psychosis
Cerevel Therapeutics
Karuna Therapeutics
AbbVie’s Cerevel deal hits an uncommon roadblock
BioPharma Dive
Wed, 02/21/24 - 11:10 am
AbbVie
Cerevel Therapeutics
M&A
FTC
antitrust
Karuna, Cerevel might be just the start of psychiatry drug M&A
BioPharma Dive
Tue, 01/23/24 - 11:17 am
M&A
Karuna Therapeutics
Cerevel Therapeutics
schizophrenia
AbbVie
Bristol Myers Squibb
All AbbVie's CEO wanted for Christmas was Cerevel—oh, and ImmunoGen, too
Fierce Biotech
Mon, 01/8/24 - 11:30 am
AbbVie
Richard Gonzalez
Cerevel Therapeutics
M&A
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy: 'This acquisition is not anti-competitive.'
Fierce Biotech
Thu, 12/7/23 - 11:08 pm
AbbVie
Cerevel Therapeutics
M&A
Richard Gonzalez
FTC
anticompetitive practices
AbbVie to buy Cerevel in $8.7B bet on brain drugs
BioPharma Dive
Wed, 12/6/23 - 09:23 pm
AbbVie
Cerevel Therapeutics
M&A
Neuroscience
The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
BioSpace
Mon, 08/14/23 - 11:23 am
depression
Biogen
SAGE Therapeutics
zuranolone
Intra-Cellular Therapies
lumateperone
Alto Neuroscience
ALTO-100
schizophrenia
Karuna Therapeutics
KarXT
Cerevel Therapeutics
emraclidine
Acadia Pharmaceuticals
pimavanserin
Axesome Therapeutics
AXS-05
Alzheimer's agitation
NRx
NRX-101
bipolar disorder
Biohaven
troriluzole
OCD
VistaGen
fasedienol
social anxiety
Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine
CNBC
Wed, 05/17/23 - 10:05 am
Google
Google Cloud
artificial intelligence
drug discovery
precision medicine
Pfizer
Colossal Biosciences
Cerevel Therapeutics
Cerevel to change up CEO as 7 data readouts near showdown
Fierce Biotech
Thu, 05/4/23 - 09:13 am
Cerevel Therapeutics
Pharma CEOs
Tony Coles
Neurosciences
clinical trials
IPOs vs SPACs
EP Vantage
Thu, 03/9/23 - 09:47 am
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Endpoints
Fri, 02/24/23 - 09:12 am
Cerevel Therapeutics
COVID-19
epilepsy
Parkinson's Disease
darigabat
CVL-871
How 2 biotechs survived 2022’s rocky market—and why their CEOs see success on the horizon
Fierce Biotech
Wed, 01/18/23 - 11:12 pm
Agios Pharmaceuticals
Cerevel Therapeutics
JPMHC 2023
layoffs
Pfizer's neuroscience spinout scores in schizophrenia
BioPharma Dive
Wed, 06/30/21 - 12:05 am
Cerevel Therapeutics
Pfizer
schizophrenia
clinical trials
Cerevel Therapeutics Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon
BioSpace
Tue, 04/13/21 - 10:17 am
Cerevel Therapeutics
Parkinson's Disease
tavapadon
Bain Capital
Novaquest
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
BioSpace
Wed, 10/28/20 - 11:09 pm
Pfizer
Cerevel Therapeutics
SPAC
Arya Sciences
NASDAQ

Pages